Table 1.
Clinical characteristics of patients and controls
| Characteristic | Patients * n = 129 | Control* n = 91 | P& |
|---|---|---|---|
| Age (years) | 24.58 ± 4.61 | 25.48 ± 3.38 | 0.115 |
| BMI (k/m2) | 24.47 ± 4.64 | 24.2 ± 3.31 | 0.65 |
| Total-cholesterol (mg/dl) | 199.86 ± 38.82 | 187.33 ± 13.77 | 0.004 |
| LDL-C (mg/dl) | 117.75 ± 29,35 | 110.31 ± 11.40 | 0.023 |
| HDL-C (mg/dl) | 56.76 ± 13.89 | 57.33 ± 4.49 | 0.705 |
| Triglycerides (mg/dl) | 122.34 ± 55.27 | 115.09 ± 24.07 | 0.004 |
| Fasting Glucose (mg/dl) | 91.43 ± 7.55 | 88.08 ± 3.96 | < 0.001 |
| Fasting insulin (mIU/ml) | 12.16 ± 9.07 | 4.71 ± 1.17 | < 0.001 |
| Homocysteine (µmol/L) | 2.63 ± 1,60 | 1.33 ± 0.22 | < 0.001 |
| FSH (mIU/ml) | 5.43 ± 1,77 | 4.17 ± 1.24 | < 0,001 |
| LH (mIU/ml) | 6.53 ± 3.68 | 4.18 ± 0.99 | < 0.001 |
| Estradiol (pg/ml) | 34.90 ± 20.83 | 39.02 ± 32.35 | 0.254 |
| DHEA-S (µg/dl) | 225.92 ± 89.32 | 222.29 ± 42.84 | 0.721 |
| 17-OHP (ng/ml) | 1.72 ± 0.87 | 0.90 ± 0.31 | < 0.001 |
| Total-Testosterone (ng/ml) | 0.99 ± 1.36 | 1.07 ± 0.69 | 0.632 |
| Free-Testosterone (pg/ml) | 3.39 ± 1,80 | 1,52 ± 0.40 | < 0.001 |
| Prolactine (pmol) | 17.08 ± 7.27 | 15.51 ± 4.49 | 0.07 |
| Fibrinogen (mg/dl) | 367.00 ± 75.07 | 277.12 ± 44.07 | < 0.001 |
| hs-CRP(mg/dl) | 0.41 ± 0.63 | 0.29 ± 0.22 | 0.730 |
*mean ± SD
&2-tailed t test
P < 0.05 values were accepted as statistically significant